In advanced gastrointestinal stromal tumors [15], bladder cancer [16], non-small cell lung cancer [17], and melanoma [18], high CDK1 expression promotes the progression of malignant tumors and exacerbates the degree of proliferation of malignant tumor cells. Here, CDK1 is linked to urinary bladder carcinoma.